HHMI
CL icon

Howard Hughes Medical Institute’s Colgate-Palmolive CL Stock Holding History

Howard Hughes Medical Institute’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-174
Closed -$13.7K – 118
2025
Q4 		$13.7K Hold
174
– – 0.01% 165
2025
Q3 		$13.9K Sell
174
-1
-0.6% -$85 0.01% 156
2025
Q2 		$15.9K Buy
+175
New +$16K 0.01% 139

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Howard Hughes Medical Institute's CL Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 174 shares — an estimated $13.7K sold.

Howard Hughes Medical Institute first reported a position in CL in Q2 2025 and held it in 3 quarters. The position peaked at $15.9K in Q2 2025. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 174 Colgate-Palmolive shares in Q1 2026, an estimated $13.7K.
  • Howard Hughes Medical Institute first reported a position in Colgate-Palmolive in Q2 2025 and held it in 3 quarters.
  • Howard Hughes Medical Institute's Colgate-Palmolive position peaked at $15.9K in Q2 2025.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.